- ¹â¸F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma
-
Laudicella R, Davidzon G, Vasanawala S, Baldari S, Iagaru A
- KMID: 2455525
- Nucl Med Mol Imaging.
- 2019 Aug;53(4):296-299.
- doi: 10.1007/s13139-019-00597-8
We described the clinical impact of ¹â¸F-FDG PET/MR in refining the evaluation of a 39-year-old female with newly diagnosed metastatic urethral adenocarcinoma.We detailed the diagnostic imaging workup focusing our attention... -
- CITED
-
- Close
- SHARE
-
- Close
